Market Cap 456.74M
Revenue (ttm) 167.29M
Net Income (ttm) 34.51M
EPS (ttm) N/A
PE Ratio 6.74
Forward PE 7.51
Profit Margin 20.63%
Debt to Equity Ratio 1.24
Volume 200,900
Avg Vol 202,664
Day's Range N/A - N/A
Shares Out 36.92M
Stochastic %K 43%
Beta 0.55
Analysts Strong Sell
Price Target $15.19

Company Profile

Crescent Capital BDC, Inc. is as a business development company is a private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Industry: Asset Management
Sector: Financial Services
Phone: 310 235 5900
Address:
11100 Santa Monica Boulevard, Suite 2000, Los Angeles, United States
Impossum
Impossum Mar. 21 at 3:56 PM
$CCAP you think you have something but then realize it's just a 🪳
0 · Reply
RunnerSignals
RunnerSignals Mar. 2 at 10:10 PM
stocks with explosive upside $QS $ORCL $NUVB $CCAP $PLTR see why analysts are buzzing and which plays could run full steam https://stocksrunner.com/news/2026-03-02-6-trending-stocks-with-the-highest-upside-potential
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:41 PM
$CCAP Q4 '25 Earnings Results & Recap Crescent Capital BDC Inc. declared a first quarter 2026 regular cash dividend of $0.42 per share, payable on April 15, 2026, to stockholders of record as of March 31, 2026.
0 · Reply
Zonata
Zonata Feb. 24 at 5:17 PM
$CCAP Started
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 10:10 PM
$CCAP RSI: 26.32, MACD: -0.1938 Vol: 0.33, MA20: 14.16, MA50: 14.30 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JackJones268
JackJones268 Feb. 11 at 3:44 PM
$CCAP Crescent Capital BDC; middle-market lending; high dividend yield; credit quality sensitive to economic cycle.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 4:15 PM
$CCAP Current Stock Price: $14.19 Contracts to trade: $15.0 CCAP Feb 20 2026 Call Entry: $0.05 Exit: $0.10 ROI: 84% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DraftsmanshipDust
DraftsmanshipDust Dec. 27 at 1:09 PM
$CCAP The setup is defined by credibility, not hype; cost controls have to translate into healthier margins — any stumble could quickly widen valuation discounts. Upside exists, but credibility must lead the way.
0 · Reply
StatSphere
StatSphere Dec. 25 at 4:16 PM
$CCAP This ticker is entering a stage where execution quality will overshadow headline narratives. Management alignment and prioritization play a larger role from here. Evidence of resilience during turbulence would be constructive. Catalysts matter, yet consistency will ultimately carry more weight.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 9 at 11:29 PM
$CCAP Share Price: $14.97 Contract Selected: Jun 18, 2026 $12.5 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.35 – $2.88 Potential Upside: 69% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on CCAP
Buy These ‘Private Equity' Plays For 10.5% Yields

Sep 15, 2024, 10:04 AM EDT - 1 year ago

Buy These ‘Private Equity' Plays For 10.5% Yields

CCAP NCDL SLRC


Crescent Capital BDC, Inc. Provides Business Update

Mar 15, 2023, 7:30 AM EDT - 3 years ago

Crescent Capital BDC, Inc. Provides Business Update

CCAP


Invest Like PE For Less With These 3 Massive Yielders

Jan 29, 2023, 8:30 AM EST - 3 years ago

Invest Like PE For Less With These 3 Massive Yielders

CCAP PNNT PSEC


Impossum
Impossum Mar. 21 at 3:56 PM
$CCAP you think you have something but then realize it's just a 🪳
0 · Reply
RunnerSignals
RunnerSignals Mar. 2 at 10:10 PM
stocks with explosive upside $QS $ORCL $NUVB $CCAP $PLTR see why analysts are buzzing and which plays could run full steam https://stocksrunner.com/news/2026-03-02-6-trending-stocks-with-the-highest-upside-potential
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:41 PM
$CCAP Q4 '25 Earnings Results & Recap Crescent Capital BDC Inc. declared a first quarter 2026 regular cash dividend of $0.42 per share, payable on April 15, 2026, to stockholders of record as of March 31, 2026.
0 · Reply
Zonata
Zonata Feb. 24 at 5:17 PM
$CCAP Started
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 10:10 PM
$CCAP RSI: 26.32, MACD: -0.1938 Vol: 0.33, MA20: 14.16, MA50: 14.30 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JackJones268
JackJones268 Feb. 11 at 3:44 PM
$CCAP Crescent Capital BDC; middle-market lending; high dividend yield; credit quality sensitive to economic cycle.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 4:15 PM
$CCAP Current Stock Price: $14.19 Contracts to trade: $15.0 CCAP Feb 20 2026 Call Entry: $0.05 Exit: $0.10 ROI: 84% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DraftsmanshipDust
DraftsmanshipDust Dec. 27 at 1:09 PM
$CCAP The setup is defined by credibility, not hype; cost controls have to translate into healthier margins — any stumble could quickly widen valuation discounts. Upside exists, but credibility must lead the way.
0 · Reply
StatSphere
StatSphere Dec. 25 at 4:16 PM
$CCAP This ticker is entering a stage where execution quality will overshadow headline narratives. Management alignment and prioritization play a larger role from here. Evidence of resilience during turbulence would be constructive. Catalysts matter, yet consistency will ultimately carry more weight.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 9 at 11:29 PM
$CCAP Share Price: $14.97 Contract Selected: Jun 18, 2026 $12.5 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.35 – $2.88 Potential Upside: 69% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 5:22 PM
Oppenheimer has updated their rating for Crescent Capital BDC ( $CCAP ) to Outperform with a price target of 19.
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 3:08 PM
Wells Fargo updates rating for Crescent Capital BDC ( $CCAP ) to Equal-Weight, target set at 15 → 14.
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 12:45 PM
Keefe, Bruyette & Woods has adjusted their stance on Crescent Capital BDC ( $CCAP ), setting the rating to Outperform with a target price of 17 → 15.5.
0 · Reply
RunnerSignals
RunnerSignals Nov. 14 at 4:43 AM
Analyst Upgrades: 150% Upside Spotted 🎯 $NEM $CCAP $BODI $TTD $ADBE lighting up with major price targets! Full breakdown inside https://stocksrunner.com/news/2025-11-13-stocks-receiving-upside-potential-and-analyst-upgrades
0 · Reply
Okadarlan
Okadarlan Sep. 30 at 9:38 AM
$BCSF $OBDE $FCPT and $CCAP on sale today.
1 · Reply
Angiesix
Angiesix Sep. 24 at 8:58 PM
$PSEC Just watch how all the social media accounts on YouTube, X etc. are trying to get you into selling BDCs because of rate cuts. Strong long $PSEC $CCAP $BBDC $NMFC
0 · Reply
Okadarlan
Okadarlan Sep. 22 at 7:32 PM
$CCAP Starter here.
0 · Reply
JarvisFlow
JarvisFlow Sep. 5 at 10:30 AM
Clear Street updates rating for Crescent Capital BDC ( $CCAP ) to Buy, target set at 16.5.
0 · Reply
RadcliffeRanges
RadcliffeRanges Aug. 23 at 8:35 AM
$CCAP Crescent Capital BDC Inc is facing credit spread volatility and funding costs
0 · Reply
Persiandoc
Persiandoc Jul. 8 at 5:08 PM
$CCAP took position https://elite.finviz.com/published_idea.ashx?t=CCAP&f=070825&i=CCAPd130710469i
0 · Reply
DonCorleone77
DonCorleone77 Jun. 1 at 7:04 PM
$CCAP Crescent Capital BDC price target lowered to $17 from $20 at BofA BofA lowered the firm's price target on Crescent Capital BDC to $17 from $20 and keeps a Buy rating on the shares. The Q1 results for the business development companies were "somewhat disappointing," with profitability weaker than expected as lower rates and spreads, tariff-related macro uncertainty, and normalizing credit weighted on reports, the analyst tells investors in a research note. However, there was only as small uptick in non-accruals to 2.9%, which remain well below the industry longer-term average, adds BofA. It remains positive on the sector.
0 · Reply